TY - JOUR
T1 - Quality of life and traditional outcome results at 1 year in elderly patients having critical limb ischemia and the role of conservative treatment
AU - Steunenberg, Stijn L.
AU - de Vries, Jolanda
AU - Raats, Jelle W.
AU - Verbogt, Nathalie
AU - Lodder, Paul
AU - van Eijck, Geert-Jan
AU - Veen, Eelco J.
AU - de Groot, Hans G. W.
AU - Ho, Gwan H.
AU - van der Laan, Lijckle
PY - 2019
Y1 - 2019
N2 - Introduction: Revascularization is the cornerstone of the treatment of critical limb ischemia (CLI), but the number of elderly frail patients increase. Revascularization is not always possible in these patients and conservative therapy seems to be an option. The goals of this study are to analyze the 1-year quality of life (QoL) results and mortality rates of elderly patients with CLI and to investigate if conservative treatment could be an acceptable treatment option. Methods: Patients with CLI >= 70 years old were included in a prospective observational cohort study in 2 hospitals in the Netherlands between 2012 and 2016 and were divided over 3 treatment modalities: endovascular therapy, surgical revascularization, and conservative treatment. The World Health Organization Quality of Life (WHOQoL-Bref) instrument, a generic QoL assessment tool that includes components of physical, psychological, social relationships and environment, was used to evaluate QoL at baseline, 6 months, and 1 year. Results: In total, 195 patients (56% male, 33% Rutherford 4, mean age of 80) were included. Physical QoL significantly increased after surgical (10.4 vs 14.9, P <.001), endovascular (10.9 vs 13.7, P <.001), and conservative therapy (11.6 vs 13.2, P = .01) at 1 year. One-year mortality was relatively low after surgery (10%) compared to endovascular (40%) and conservative therapy (37%). Conclusion: The results of this study could not be used to designate the superior treatment used in elderly patients with CLI. Conservative treatment could be an acceptable treatment option in selected patients with CLI unfit for revascularization. Treatment of choice in elderly patients with CLI is based on multiple factors and should be individualized in a shared decision-making process.
AB - Introduction: Revascularization is the cornerstone of the treatment of critical limb ischemia (CLI), but the number of elderly frail patients increase. Revascularization is not always possible in these patients and conservative therapy seems to be an option. The goals of this study are to analyze the 1-year quality of life (QoL) results and mortality rates of elderly patients with CLI and to investigate if conservative treatment could be an acceptable treatment option. Methods: Patients with CLI >= 70 years old were included in a prospective observational cohort study in 2 hospitals in the Netherlands between 2012 and 2016 and were divided over 3 treatment modalities: endovascular therapy, surgical revascularization, and conservative treatment. The World Health Organization Quality of Life (WHOQoL-Bref) instrument, a generic QoL assessment tool that includes components of physical, psychological, social relationships and environment, was used to evaluate QoL at baseline, 6 months, and 1 year. Results: In total, 195 patients (56% male, 33% Rutherford 4, mean age of 80) were included. Physical QoL significantly increased after surgical (10.4 vs 14.9, P <.001), endovascular (10.9 vs 13.7, P <.001), and conservative therapy (11.6 vs 13.2, P = .01) at 1 year. One-year mortality was relatively low after surgery (10%) compared to endovascular (40%) and conservative therapy (37%). Conclusion: The results of this study could not be used to designate the superior treatment used in elderly patients with CLI. Conservative treatment could be an acceptable treatment option in selected patients with CLI unfit for revascularization. Treatment of choice in elderly patients with CLI is based on multiple factors and should be individualized in a shared decision-making process.
KW - quality of life
KW - critical limb ischemia
KW - conservative therapy
KW - elderly patients
KW - TREATMENT STRATEGIES
KW - DOUBLE-BLIND
KW - REVASCULARIZATION
KW - TRIAL
KW - MULTICENTER
KW - MANAGEMENT
KW - AMPUTATION
KW - MORTALITY
KW - BYPASS
KW - RISK
U2 - 10.1177/1538574419885478
DO - 10.1177/1538574419885478
M3 - Article
SN - 1538-5744
VL - 54
SP - 126
EP - 134
JO - Vascular and endovascular surgery
JF - Vascular and endovascular surgery
IS - 2
ER -